...
首页> 外文期刊>International Journal of Applied Biology and Pharmaceutical Technology >FABRICATION AND EVALUATION OF ETHYL CELLULOSE AND CELLULOSE ACETATE COATED CONTROLLED RELEASE MULTIPARTICULATE FORMULATION OF KETOPROFEN BY DRY POWDER LAYERING TECHNOLOGY
【24h】

FABRICATION AND EVALUATION OF ETHYL CELLULOSE AND CELLULOSE ACETATE COATED CONTROLLED RELEASE MULTIPARTICULATE FORMULATION OF KETOPROFEN BY DRY POWDER LAYERING TECHNOLOGY

机译:干粉分层技术制备和评价乙基纤维素和醋酸纤维素包覆的酮洛芬控释多颗粒制剂

获取原文

摘要

Multiparticulate is one of the most widely accepted technologies in thepharmaceutical industries.Present study aim is to prepare controlled release multiparticulate ofKetoprofen by drug powder layering technology using two different release retardant (EthylCellulose & Cellulose Acetate) in five different drug: release retardant concentrations (5%, 10%,20%, 30% & 40%). The most widely used multiparticulate system in pharmaceutical industries isDry Powder Layering Technique. Powder layering involves the deposition of successive layersof dry powder(s) and excipients on preformed nuclei or cores with the help of binding liquids.The prepared multiparticles were evaluated for friability, drug content uniformity, density andpercentage yield. The release rate was evaluated by dissolution studies. To establish drugpolymer compatibility DSC and FT IR was done. Study concluded that Dry Powder Layering ofKetoprofen can be effectively used for drug loading on non-pareil seeds. It was also found thatformulation having Ethyl Cellulose have more retarding capacity than the Cellulose Acetate inboth formulationsand drug release follows Zero order kinetics. DSC and FT IR study concludedthat there is no interaction between EC and CA.From dissolution parameter of the preparedmultiparticles it is concluded that formulation EC3 (20%) and CA4 (30%) posses the requiredcharacteristics of oral controlled release formulation. It is assumed that above 90% of the drugwill be released within 24 hours. Hence this formulation can be used as once daily dosageregimen for the controlled release of Ketoprofen.
机译:多重颗粒是制药行业中最广泛接受的技术之一。目前的研究目标是通过药物粉末分层技术,使用两种不同的释放抑制剂(乙基纤维素和醋酸纤维素)在五种不同的药物中制备酮洛芬的控释多颗粒:释放抑制剂浓度(5%) ,10%,20%,30%和40%)。制药工业中使用最广泛的多颗粒系统是干粉分层技术。粉末分层涉及在结合液的帮助下将连续的干粉和赋形剂层沉积在预形成的核或核上,评估制备的多颗粒的易碎性,药物含量均匀性,密度和百分率。通过溶出度研究评估释放速率。为了建立药物聚合物相容性,进行了DSC和FT IR。研究得出的结论是,酮洛芬的干粉分层可有效地将药物负载在非pareil种子上。还发现在两种制剂中具有乙基纤维素的制剂比乙酸纤维素具有更大的阻滞能力,并且药物释放遵循零级动力学。 DSC和FT IR研究得出结论,EC和CA之间没有相互作用。从制备的多颗粒的溶出参数可以得出结论,EC3(20%)和CA4(30%)制剂具有口服控释制剂所需的特性。假定超过90%的药物将在24小时内释放。因此,该制剂可用作每日一次剂量给药方案,用于酮洛芬的控释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号